IMCIVREE^® (setmelanotide) injection –
NOW FDA-APPROVED FOR
A NEW INDICATION > Learn More

Skip to content

Healthcare Professionals
Careers
Investors & Media
International

Healthcare Professionals
Careers
Investors & Media
International

Science
Clinical Trials
Patients
- Disease Focus
Product
About

Science
Clinical Trials
Patients
- Disease Focus
Product
About

Science
Clinical Trials
Patients
- Disease Focus
Product
About

Healthcare Professionals
Careers
Investors & Media
International

International

Terms of Use
Privacy Policy
California Compliance
Cookie Settings

Terms of Use
Privacy Policy
California Compliance
Cookie Settings

Linkedin-in X-twitter

Rhythm Pharmaceuticals, Inc.
222 Berkeley Street, 12th Floor
Boston, MA 02116

This website is intended only for residents of the United States.

© 2024, Rhythm Pharmaceuticals, Inc. All Rights Reserved. Rhythm, IMCIVREE, GOLD Academy, LEAD for Rare Obesity, Uncovering Rare Obesity, Pioneering a path forward and their logos are trademarks of Rhythm Pharmaceuticals, Inc.

US-RHY-2400016 09/2024

NOW FDA-
APPROVED
FOR A NEW INDICATION

You are about to leave Rhythm Pharmaceuticals.